Status:
UNKNOWN
Cardiovascular Involvement in Patients With Granulomatosis With Polyangiitis
Lead Sponsor:
Medical University of Warsaw
Conditions:
Granulomatosis With Polyangiitis
Atherosclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Granulomatosis with polyangiitis (GPA) is one of antineutrophil cytoplasmic autoantibody (ANCA) - associated vasculitis. Inflammation-induced thrombosis is considered to be a feature of systemic autoi...
Detailed Description
Granulomatosis with polyangiitis (Wegener's; GPA) is an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), which also includes microscopic polyangiitis and eosinophilic granulomat...
Eligibility Criteria
Inclusion
- Newly diagnosed Granulomatosis with polyangitis
Exclusion
- \-
Key Trial Info
Start Date :
February 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03782870
Start Date
February 1 2010
End Date
December 30 2019
Last Update
December 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Family Medicine, Internal and Metabolic Diseases
Warsaw, Poland